SCHEMBL29472005

SCHEMBL29472005

N#Cc1ccc(C(=O)O)cc1C#N

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.59
HPGD P15428 1/20 0.59
TSHR P16473 2/20 0.46
TP53 P04637 1/20 0.46
CA12 O43570 2/20 0.45
CA1 P00915 2/20 0.45
CA2 P00918 2/20 0.45
CA4 P22748 2/20 0.45
CA6 P23280 2/20 0.45
CA7 P43166 2/20 0.45
CA9 Q16790 2/20 0.45
CA14 Q9ULX7 2/20 0.45
KDM4E B2RXH2 1/20 0.45
POLB P06746 1/20 0.45
GAA P10253 1/20 0.45
MAPT P10636 1/20 0.45
PTGS2 P35354 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
TPMT P51580 1/20 0.44
XDH P47989 4/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4844022 1.00 ALDH1A1 (0.59) ALDH1A1HPGDTSHRTP53CA12
SCHEMBL30786930 0.88 ALDH1A1 (0.54) ALDH1A1HPGDTSHRTP53CA12
SCHEMBL22530492 0.88 ALDH1A1 (0.54) ALDH1A1HPGDTSHRTP53CA12
SCHEMBL13812238 0.87 ALDH1A1 (0.60) ALDH1A1HPGDTSHRCA12CA1
SCHEMBL1419879 0.85 ALDH1A1 (0.62) ALDH1A1HPGDTSHRCA12CA1
SCHEMBL28343052 0.85 ALDH1A1 (0.50) ALDH1A1HPGDTSHRTP53CA12
SCHEMBL15393730 0.84 ALDH1A1 (0.45) ALDH1A1HPGDTSHRCA1CA2
SCHEMBL2051393 0.84 XDH (0.50) KDM4EXDH
SCHEMBL2820180 0.83 ALDH1A1 (0.49) ALDH1A1HPGDTSHRTP53CA12
SCHEMBL1267736 0.83 KDM4E (0.57) ALDH1A1HPGDTSHRTP53CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115160285-A Thioamides ALDH 2 Agonist, preparation method and application 云南大学 2022-10-11 CN disclosed
CN-114173772-A Inhibitors of CD40-CD154 binding 托尼克斯医药控股公司 2022-03-11 CN disclosed